Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Sabra Health Care REIT, Inc.
SBRA
NASDAQ·Real Estate·REIT - Healthcare Facilities·Mkt cap $5.0B
$20.16
▲ +2.44%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$17.17 - $21.28
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 6.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Diversified portfolio across five healthcare property types reduces tenant and revenue concentration risk
- Large-scale operations with 41,445 beds/units providing economies of scale and operational efficiency
- Geographic diversification across United States and Canada markets
- Established relationships with leading healthcare operators and property managers
- REIT structure providing tax-efficient income distribution and access to capital markets
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Aging U.S. and Canadian populations increasing demand for senior housing and skilled nursing care
Value
Attractively priced below Healthcare REITs peer average
Momentum
Stable
-0.9% over 3m
Quality
Excellent
Strong fundamentals
Dividend
High yield
6.10% yield
Smart-money signal
Who's buying SBRA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 3, 2026
APR 29, 2026
Reported EPS of $0.16 vs $0.16 consensus (-0.9% surprise). Revenue of $221.8M vs $209.2M expected (+6.0%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-0.9%
Next: Aug 3, 2026
Revenue trend · last 8Q
—
—
+12%
+10%
+7%
+7%
+16%
+21%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$176.1M
$178.0M
$182.3M
$183.5M
$189.2M
$190.0M
$211.9M
$221.8M
Margins · last 8Q
Gross
61.4%
Operating
17.8%
Profit
18.4%
Wall Street consensus
7 analysts · 29% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
29%
Hold
71%
Sell
0%
Median Price Target
$22.00
▲ +9.1% vs $20.16
Latest: Citi · Jun 22, 2026
3 analysts covering